Tumay Ak et al. 2024. Secukinumab after first-line tumor necrosis factor-alpha inhibitor therapy in psoriatic arthritis: A real-world retrospective cohort study. Archives of Rheumatology. 39, 1 (Mar. 2024), 071–080. DOI:https://doi.org/10.46497/ArchRheumatol.2024.10050.